Haleon Sees Year-End Revenue Hit by Weak Cold and Flu Season
Bloomberg•2026-02-25 18:52
🤖 AI Summary
Haleon Plc shares plunged the most in a year as the company projected weaker-than-expected revenue growth for 2025, attributed to a weak cold and flu season dampening over-the-counter medicine purchases.
📊 Comment: Performance varies for defensive stocks depending on earnings.
Haleon Plc shares plunged the most in a year as the company projected weaker-than-expected revenue growth for 2025, attributed to a weak cold and flu season dampening over-the-counter medicine purchases.
📊 Comment: Performance varies for defensive stocks depending on earnings.
📊 Positive/Negative Vote
Be the first to vote!
🔗 Related News
💬 0 Comments
No comments yet. Be the first to comment!